Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Ancriviroc

Ancriviroc
Ancriviroc (SCH-351125) is an oxime-piperidine compound with strong antiretroviral activity and an orally bioavailable small molecule chemokine receptor CCR5 antagonist (Kd value 9.27nM) that enters HIV-1 through the CCR5 co-receptor and is used to study HIV-1.
Catalog No. T30047Cas No. 370893-06-4
Select Batch
Purity:99.74%
Contact us for more batch information

Resource Download

Ancriviroc

Catalog No. T30047Alias Schering C, SCH-351125, CHEMBL336672, AC1NUILE, [3H]ancrivirocCas No. 370893-06-4

Ancriviroc (SCH-351125) is an oxime-piperidine compound with strong antiretroviral activity and an orally bioavailable small molecule chemokine receptor CCR5 antagonist (Kd value 9.27nM) that enters HIV-1 through the CCR5 co-receptor and is used to study HIV-1.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$195In Stock
5 mg$483In Stock
10 mg$692In Stock
25 mg$1,080In Stock
50 mg$1,490In Stock
100 mg$1,970In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Ancriviroc"

Product Introduction

Bioactivity
Description
Ancriviroc (SCH-351125) is an oxime-piperidine compound with strong antiretroviral activity and an orally bioavailable small molecule chemokine receptor CCR5 antagonist (Kd value 9.27nM) that enters HIV-1 through the CCR5 co-receptor and is used to study HIV-1.
In vitro
METHODS: Chinese hamster ovary (CHO) cell membranes expressing human CCR5 were incubated with Ancriviroc (SCH-351125) (10-0.3 nM), and Ki values ​​were calculated using GRAPHPAD PRISM software based on experimentally determined IC50 and KD values.
RESULTS Ancriviroc (SCH-351125) inhibited the binding of RANTES to CHO cell membranes expressing human CCR5 in a dose-dependent manner with a Ki value of 2.9 nM; Ancriviroc (SCH-351125) bound to CCR5 with high affinity with a KD of 9.27 nM. [1]
In vivo
METHODS: In a SCID-mouse model treated with (SCH-351125) (30 mg/kg, orally, daily), HLA-ABC levels on implanted cells from treated and untreated mice were measured by FACS analysis using mAb W6/32.
RESULTS SCH-C had potent and dose-dependent antiviral activity in the SCID-mouse model; MHC class I expression on implanted cells from (SCH-351125)-treated mice was reduced in a dose-dependent manner, further confirming the inhibition of viral replication by SCH-C. [1]
AliasSchering C, SCH-351125, CHEMBL336672, AC1NUILE, [3H]ancriviroc
Chemical Properties
Molecular Weight557.52
FormulaC28H37BrN4O3
Cas No.370893-06-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (89.68 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7937 mL8.9683 mL17.9366 mL89.6829 mL
5 mM0.3587 mL1.7937 mL3.5873 mL17.9366 mL
10 mM0.1794 mL0.8968 mL1.7937 mL8.9683 mL
20 mM0.0897 mL0.4484 mL0.8968 mL4.4841 mL
50 mM0.0359 mL0.1794 mL0.3587 mL1.7937 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ancriviroc | purchase Ancriviroc | Ancriviroc cost | order Ancriviroc | Ancriviroc chemical structure | Ancriviroc in vivo | Ancriviroc in vitro | Ancriviroc formula | Ancriviroc molecular weight